Strategic Highlights
- Executed $63M in share repurchases in the quarter; $434M in
total executed through April 30, 2024, at an average price of $5.42
per share
- Enact announced an increase to its quarterly dividend, as well
as a new share repurchase program with authorization to purchase up
to $250M of common stock
- Continued progress on the LTC1 multi-year rate action plan
(MYRAP) with $41M of gross incremental premium approvals; $28.3B
net present value achieved from in-force rate actions (IFAs) since
2012
- CareScout continued to expand the CareScout Quality Network, a
first-of-its-kind group of long-term care providers who meet high
quality standards and are committed to person-centered care
Financial Highlights
- Net income2 of $139M, or $0.31 per diluted share, and adjusted
operating income2,3 of $85M, or $0.19 per diluted share
- Enact reported adjusted operating income of $135M2; distributed
$61M in capital returns to Genworth
- U.S. life insurance companies’ RBC4 ratio of 314%5 driven by
strong statutory income
- Genworth holding company cash and liquid assets of $253M at
quarter-end
Genworth Financial, Inc. (NYSE: GNW) today reported results for
the quarter ended March 31, 2024.
“I’m pleased with Genworth’s solid performance to start the
year,” said Tom McInerney, President & CEO. “Enact recorded yet
another strong quarter, evidenced by continued growth in equity and
today’s return of capital announcements. We further strengthened
the financial stability of our LTC legacy block and returned $63
million to shareholders through share repurchases. We remain
focused on executing our strategy and laying the foundation for
long-term growth through CareScout. The recently launched CareScout
Quality Network will drive better care outcomes for our LTC
policyholders who select in-network providers, allowing them to
extend their benefits while driving significant claims savings for
Genworth.”
Consolidated Metrics
Q1 2024
Q4 2023
Q1 2023
(Amounts in millions, except per share
data)
Net income (loss)2
$
139
$
(212)
$
122
Earnings (loss) per diluted share2
$
0.31
$
(0.47)
$
0.24
Adjusted operating income (loss)2,3
$
85
$
(230)
$
144
Adjusted operating income (loss) per
diluted share2,3
$
0.19
$
(0.51)
$
0.29
Weighted-average diluted shares6
450.3
449.4
500.1
Consolidated GAAP Financial
Highlights
- Net income in the quarter was driven by Enact, which had very
strong operating performance, as well as positive LTC earnings,
partially offset by losses in Corporate and Other
- Net investment gains, net of taxes, increased net income by $39
million in the current quarter, compared with net investment gains
of $30 million in the prior quarter and net investment losses of $9
million in the prior year. The investment gains in the current
quarter were driven primarily by mark-to-market adjustments on
limited partnerships and equity securities, partially offset by net
trading losses
- Changes in the fair value of market risk benefits, net of
taxes, increased net income by $18 million in the quarter driven
primarily by the favorable change in the interest rate yield curve,
compared with decreases of $11 million in the prior quarter and $13
million in the prior year
- Net investment income was $782 million in the quarter, down
from $810 million in the prior quarter primarily driven by lower
income from limited partnerships
Enact
GAAP Operating Metrics
Q1 2024
Q4 2023
Q1 2023
(Dollar amounts in millions)
Adjusted operating income2
$
135
$
129
$
143
Primary new insurance written
$
10,526
$
10,453
$
13,154
Loss ratio
8%
10%
(5)%
Equity7
$
3,846
$
3,785
$
3,514
- Current quarter results reflect a pre-tax reserve release of
$54 million primarily from favorable cure performance on
delinquencies from early 2023 and prior. The prior quarter and
prior year included pre-tax reserve releases of $53 million and $70
million, respectively
- Net investment income of $57 million in the current quarter was
up from $46 million in the prior year from higher yields and higher
average invested assets
- Primary insurance in-force increased four percent versus the
prior year to $264 billion driven by new insurance written (NIW)
and continued elevated persistency
- Primary NIW was down 20 percent versus the prior year primarily
due to a smaller mortgage insurance market and elevated mortgage
rates
- New delinquencies increased 19 percent to 11,395 from 9,599 in
the prior year primarily from the aging of large, newer books. New
delinquencies for the quarter were more than offset by strong cure
performance
Capital Metric
Q1 2024
Q4 2023
Q1 2023
PMIERs Sufficiency Ratio5,8
163
%
161
%
164
%
- Enact announced an increase to its quarterly dividend from
$0.16 to $0.185 per share, payable in June 2024
- Enact also announced a new share repurchase program with
authorization to purchase up to $250 million of common stock
- Enact paid a quarterly dividend of $0.16 per share in the
current quarter
- Estimated PMIERs sufficiency ratio of 163 percent, $1,883
million above requirements
Long-Term Care
Insurance
GAAP Operating Metrics
Q1 2024
Q4 2023
Q1 2023
(Amounts in millions)
Adjusted operating income (loss)
$
3
$
(151)
$
23
Premiums
$
578
$
615
$
616
Net investment income
$
464
$
489
$
473
Liability remeasurement gains (losses)
$
16
$
(188)
$
32
Cash flow assumption updates
2
(61)
(21)
Actual to expected experience
14
(127)
53
- Premiums decreased versus the prior quarter primarily driven by
seasonal trends and versus the prior year primarily from policy
terminations and policies entering paid-up status. While legal
settlements have reduced LTC tail-risk, they have accelerated the
decline in renewal premiums, which also decreased the premium
impact from IFAs versus the prior quarter
- Net investment income declined versus the prior quarter and the
prior year driven primarily by lower limited partnership
income
- Current quarter liability remeasurement gain included
seasonally high mortality, though lower than the prior year
- Prior quarter included a liability remeasurement loss of $188
million pre-tax, which included $61 million of assumption
updates
Life and
Annuities
GAAP Adjusted Operating Income
(Loss)
Q1 2024
Q4 2023
Q1 2023
(Amounts in millions)
Life Insurance
$
(33)
$
(206)
$
(27)
Fixed Annuities
11
9
14
Variable Annuities
7
14
9
Total Life and Annuities
$
(15)
$
(183)
$
(4)
Life Insurance
- Results reflect unfavorable impact from seasonally high
mortality, though lower than the prior year
- Premiums and deferred acquisition costs amortization were lower
versus the prior year primarily driven by block runoff
- Prior quarter included an unfavorable $179 million after-tax
impact for annual assumption updates
Annuities
- Fixed annuities results included favorable mortality. Lower net
spreads primarily related to block runoff versus the prior
year
- Prior quarter variable annuities results included favorable
impacts of annual assumption updates
U.S. Life Insurance Companies9
Statutory Results and RBC
(Dollar amounts in millions)
Q1 2024
Q4 2023
Q1 2023
Statutory Pre-Tax Income (Loss)5,10
$
258
$
148
$
192
Long-Term Care Insurance
151
(9)
138
Life Insurance
(18)
82
(23)
Fixed Annuities
17
16
25
Variable Annuities
108
59
52
GLIC Consolidated RBC Ratio5
314%
303%
295%
- Statutory pre-tax income was $258 million in the current
quarter:
- LTC continued to benefit from premium increases and benefit
reductions from IFAs and legal settlements, as well as the
favorable impacts of seasonally high mortality
- Life insurance results included unfavorable impacts of
seasonally high mortality. Prior quarter results included a $99
million pre-tax benefit from annual assumption updates
- Fixed annuities results reflect favorable mortality, but lower
net spread income primarily from block runoff
- Variable annuity results included a benefit from the impact of
equity market and interest rate performance
- Current quarter GLIC consolidated RBC ratio was 314 percent, up
from the prior quarter driven primarily by earnings in LTC and
variable annuities
Corporate and Other
- The current quarter adjusted operating loss was $38 million, up
from $25 million in the prior quarter and $18 million in the prior
year primarily driven by $15 million of tax related timing items
and higher expenses related to CareScout
Holding Company Cash and Liquid
Assets
(Amounts in millions)
Q1 2024
Q4 2023
Q1 2023
Holding Company Cash and Liquid
Assets11,12
$
253
$
350
$
233
- Cash and liquid assets of $253 million remained above the
company’s cash target of two-times annual debt service
- Cash inflows during the current quarter consisted of $61
million from Enact capital returns, which included a $21 million
quarterly dividend and $40 million in share repurchase
proceeds
- Current quarter cash outflows included $78 million primarily
related to employee benefit payments, which are reimbursed by the
subsidiary businesses, $63 million in share repurchases, $12
million related to debt servicing costs and the repurchase of $6
million principal of the company’s subordinated notes
Returns to Shareholders
- In the first quarter of 2024, the company repurchased $63
million of its common stock at an average price of $6.17 per share
leaving 440 million shares outstanding at the end of the
quarter
About Genworth Financial
Genworth Financial, Inc. (NYSE: GNW) is a Fortune 500 company
focused on empowering families to navigate the aging journey with
confidence, now and in the future. Headquartered in Richmond,
Virginia, Genworth provides guidance, products, and services that
help people understand their caregiving options and fund their
long-term care needs. Genworth is also the parent company of
publicly traded Enact Holdings, Inc. (Nasdaq: ACT), a leading U.S.
mortgage insurance provider. For more information on Genworth,
visit genworth.com, and for more information on Enact Holdings,
Inc. visit enactmi.com.
Conference Call Information
Investors are encouraged to read this press release, summary
presentation and financial supplement which are now posted on the
company’s website, http://investor.genworth.com.
Genworth will conduct a conference call on May 2, 2024 at 9:00
a.m. (ET) to discuss its first quarter results, which will be
accessible via:
- Telephone: 888-208-1820 or 323-794-2110 (outside the U.S.);
conference ID # 9022176; or
- Webcast:
https://investor.genworth.com/news-events/ir-calendar
Allow at least 15 minutes prior to the call time to register for
the call. A replay of the webcast will be available on the
company’s website for one year.
Prior to Genworth’s conference call, Enact will hold a
conference call on May 2, 2024 at 8:00 a.m. (ET) to discuss its
first quarter results, which will be accessible via:
- Telephone: Click here to obtain a dial-in number and unique PIN
for Enact’s live question and answer session; or
- Webcast: http://ir.enactmi.com/news-and-events/events
Allow at least 15 minutes prior to the call time to register for
the call.
Use of Non-GAAP Measures
Management uses non-GAAP financial measures entitled "adjusted
operating income (loss)" and "adjusted operating income (loss) per
share” to evaluate performance and allocate resources. Adjusted
operating income (loss) per share is derived from adjusted
operating income (loss). The company defines adjusted operating
income (loss) as income (loss) from continuing operations excluding
the after-tax effects of income (loss) attributable to
noncontrolling interests, net investment gains (losses), changes in
fair value of market risk benefits and associated hedges, gains
(losses) on the sale of businesses, gains (losses) on the early
extinguishment of debt, restructuring costs and infrequent or
unusual non-operating items. A component of the company’s net
investment gains (losses) is the result of estimated future credit
losses, the size and timing of which can vary significantly
depending on market credit cycles. In addition, the size and timing
of other investment gains (losses) can be subject to the company’s
discretion and are influenced by market opportunities, as well as
asset-liability matching considerations. The company excludes net
investment gains (losses), changes in fair value of market risk
benefits and associated hedges, gains (losses) on the sale of
businesses, gains (losses) on the early extinguishment of debt,
restructuring costs and infrequent or unusual non-operating items
from adjusted operating income (loss) because, in the company’s
opinion, they are not indicative of overall operating
performance.
While some of these items may be significant components of net
income (loss) determined in accordance with GAAP, the company
believes that adjusted operating income (loss), and measures that
are derived from or incorporate adjusted operating income (loss),
including adjusted operating income (loss) per share on a basic and
diluted basis, are appropriate measures that are useful to
investors because they identify the income (loss) attributable to
the ongoing operations of the business. Management also uses
adjusted operating income (loss), among other key performance
indicators, as a basis for determining awards and compensation for
senior management and to evaluate performance on a basis comparable
to that used by analysts. However, the items excluded from adjusted
operating income (loss) have occurred in the past and could, and in
some cases will, recur in the future. Adjusted operating income
(loss) and adjusted operating income (loss) per share on a basic
and diluted basis are not substitutes for net income (loss) or net
income (loss) per share on a basic and diluted basis determined in
accordance with GAAP. In addition, the company’s definition of
adjusted operating income (loss) may differ from the definitions
used by other companies.
Adjustments to reconcile net income (loss) to adjusted operating
income (loss) assume a 21 percent tax rate and are net of the
portion attributable to noncontrolling interests. Changes in fair
value of market risk benefits and associated hedges are adjusted to
exclude changes in reserves, attributed fees and benefit
payments.
The tables at the end of this press release provide a
reconciliation of net income (loss) available to Genworth
Financial, Inc.'s common stockholders to adjusted operating income
(loss) for the three months ended March 31, 2024 and 2023, as well
as the three months ended December 31, 2023 and reflect adjusted
operating income (loss) as determined in accordance with accounting
guidance related to segment reporting.
Statutory Accounting Data
The company presents certain supplemental statutory data for
GLIC and its consolidating life insurance subsidiaries that has
been prepared on the basis of statutory accounting principles
(SAP). GLIC and its consolidating life insurance subsidiaries file
financial statements with state insurance regulatory authorities
and the National Association of Insurance Commissioners that are
prepared using SAP, an accounting basis either prescribed or
permitted by such authorities. Due to differences in methodology
between SAP and GAAP, the values for assets, liabilities and
equity, and the recognition of income and expenses, reflected in
financial statements prepared in accordance with GAAP are
materially different from those reflected in financial statements
prepared under SAP. This supplemental statutory data should not be
viewed as an alternative to, or used in lieu of, GAAP.
This supplemental statutory data includes the company action
level RBC ratio for GLIC and its consolidating life insurance
subsidiaries as well as combined statutory pre-tax earnings from
the principal U.S. life insurance companies, GLIC, GLAIC and
GLICNY. Statutory pre-tax earnings represent the net gain from
operations, including the impact from in-force rate actions, before
dividends to policyholders, refunds to members and federal income
taxes and before realized capital gains or (losses). The combined
product level statutory pre-tax earnings are grouped on a
consistent basis as those provided on page six of the statutory
Annual Statements. Management uses and provides this supplemental
statutory data because it believes it provides a useful measure of,
among other things, statutory pre-tax earnings and the adequacy of
capital. Management uses this data to measure against its policy to
manage the U.S. life insurance companies with internally generated
capital.
Cautionary Note Regarding Forward-Looking Statements
This press release contains certain “forward-looking statements”
within the meaning of the Private Securities Litigation Reform Act
of 1995. Forward-looking statements may be identified by words such
as “expects,” “intends,” “anticipates,” “plans,” “believes,”
“seeks,” “estimates,” “will” or words of similar meaning and
include, but are not limited to, statements regarding the outlook
for the company’s future business and financial performance.
Examples of forward-looking statements include statements the
company makes relating to potential dividends or share repurchases;
future return of capital by Enact Holdings, Inc. (Enact Holdings),
including share repurchases, and quarterly and special dividends;
the cumulative economic benefit of approved and future rate actions
contemplated in the company’s long-term care insurance multi-year
in-force rate action plan; future financial performance, including
the expectation that adverse quarterly variances between actual and
expected experience could persist resulting in future remeasurement
losses in the company’s long-term care insurance business; future
financial condition of the company’s businesses; liquidity and new
lines of business or new products and services, such as those the
company is pursuing with its CareScout business (CareScout); as
well as statements the company makes regarding the potential
occurrence of a recession.
Forward-looking statements are based on management’s current
expectations and assumptions, which are subject to inherent
uncertainties, risks and changes in circumstances that are
difficult to predict. Actual outcomes and results may differ
materially from those in the forward-looking statements due to
global political, economic, inflation, business, competitive,
market, regulatory and other factors and risks, including but not
limited to, the following:
- the inability to successfully launch new lines of business,
including long-term care insurance and other products and services
the company is pursuing with CareScout;
- the company’s failure to maintain self-sustainability of its
legacy life insurance subsidiaries, including as a result of the
inability to achieve desired levels of in-force rate actions and/or
the timing of its future premium rate increases and associated
benefit reductions taking longer to achieve than originally
assumed; other regulatory actions negatively impacting the
company’s life insurance businesses;
- inaccuracies or changes in estimates, assumptions,
methodologies, valuations, projections and/or models, which result
in inadequate reserves or other adverse results (including as a
result of any changes in connection with quarterly, annual or other
reviews);
- the impact on holding company liquidity caused by an inability
to receive dividends or any other returns of capital from Enact
Holdings, and limited sources of capital and financing and the need
to seek additional capital on unfavorable terms;
- adverse changes to the structure or requirements of Federal
National Mortgage Association (Fannie Mae), Federal Home Loan
Mortgage Corporation (Freddie Mac) or the U.S. mortgage insurance
market; an increase in the number of loans insured through federal
government mortgage insurance programs, including those offered by
the Federal Housing Administration; the inability of Enact Holdings
and/or its U.S. mortgage insurance subsidiaries to continue to meet
the requirements mandated by PMIERs (or any adverse changes
thereto), inability to meet minimum statutory capital requirements
of applicable regulators or the mortgage insurer eligibility
requirements of Fannie Mae or Freddie Mac;
- changes in economic, market and political conditions including
as a result of elevated inflation, labor shortages and elevated
interest rates, which could heighten the risk of a future
recession; unanticipated financial events, which could lead to
market-wide liquidity problems and other significant market
disruption resulting in losses, defaults or credit rating
downgrades of other financial institutions; deterioration in
economic conditions, a recession or a decline in home prices, all
of which could be driven by many potential factors; political and
economic instability or changes in government policies, and
fluctuations in international securities markets;
- downgrades in financial strength and credit ratings and
potential adverse impacts to liquidity; counterparty credit risks;
defaults by counterparties to reinsurance arrangements or
derivative instruments; defaults or other events impacting the
value of invested assets;
- changes in tax rates or tax laws, or changes in accounting and
reporting standards;
- litigation and regulatory investigations or other actions,
including commercial and contractual disputes with
counterparties;
- the inability to retain, attract and motivate qualified
employees or senior management;
- the loss of significant key customers and distribution
relationships by Enact Holdings;
- the impact from deficiencies in the company’s disclosure
controls and procedures or internal control over financial
reporting;
- the occurrence of natural or man-made disasters, including
geopolitical tensions and war (including the Russian invasion of
Ukraine and the Israel-Hamas conflict), a public health emergency,
including pandemics, or climate change;
- the inability to effectively manage information technology
systems (including artificial intelligence), cyber incidents or
other failures, disruptions or security breaches of the company or
its third-party vendors, as well as unknown risks and uncertainties
associated with artificial intelligence;
- the inability of third-party vendors to meet their obligations
to the company;
- the lack of availability, affordability or adequacy of
reinsurance to protect the company against losses;
- a decrease in the volume of high loan-to-value home mortgage
originations or an increase in the volume of mortgage insurance
cancellations;
- unanticipated claims against Enact Holdings’ delegated
underwriting program;
- the impact of medical advances such as genetic research and
diagnostic imaging, emerging new technology, including artificial
intelligence and related legislation; and
- other factors described in the risk factors contained in Item
1A of the company’s Annual Report on Form 10-K filed with the U.S.
Securities and Exchange Commission on February 29, 2024.
The company provides additional information regarding these
risks and uncertainties in its Annual Report on Form 10-K. Unlisted
factors may present significant additional obstacles to the
realization of forward-looking statements. Accordingly, for the
foregoing reasons, the company cautions you against relying on any
forward-looking statements. The company undertakes no obligation to
publicly update any forward-looking statement, whether as a result
of new information, future developments or otherwise, except as may
be required under applicable securities laws.
Condensed Consolidated
Statements of Income
(Amounts in millions, except
per share amounts)
(Unaudited)
Three months
Three months ended
ended
March 31,
December 31,
2024
2023
2023
Revenues:
Premiums
$
875
$
915
$
904
Net investment income
782
787
810
Net investment gains (losses)
49
(11
)
38
Policy fees and other income
158
163
159
Total revenues
1,864
1,854
1,911
Benefits and expenses:
Benefits and other changes in policy
reserves
1,203
1,176
1,233
Liability remeasurement (gains) losses
(8
)
(15
)
416
Changes in fair value of market risk
benefits and associated hedges
(23
)
17
14
Interest credited
125
126
124
Acquisition and operating expenses, net of
deferrals
236
240
248
Amortization of deferred acquisition costs
and intangibles
65
72
63
Interest expense
30
29
30
Total benefits and expenses
1,628
1,645
2,128
Income (loss) from continuing operations
before income taxes
236
209
(217
)
Provision (benefit) for income taxes
66
55
(36
)
Income (loss) from continuing
operations
170
154
(181
)
Loss from discontinued operations, net of
taxes
(1
)
—
(2
)
Net income (loss)
169
154
(183
)
Less: net income attributable to
noncontrolling interests
30
32
29
Net income (loss) available to Genworth
Financial, Inc.'s common stockholders
$
139
$
122
$
(212
)
Income (loss) from continuing operations
available to Genworth Financial, Inc.'s
common stockholders per share:
Basic
$
0.32
$
0.25
$
(0.47
)
Diluted
$
0.31
$
0.24
$
(0.47
)
Net income (loss) available to Genworth
Financial, Inc.'s common stockholders
per share:
Basic
$
0.31
$
0.25
$
(0.47
)
Diluted
$
0.31
$
0.24
$
(0.47
)
Weighted-average common shares
outstanding:
Basic
443.0
492.3
449.4
Diluted6
450.3
500.1
449.4
Reconciliation of Net Income
(Loss) to Adjusted Operating Income (Loss)
(Amounts in millions, except
per share amounts)
(Unaudited)
Three
Three
months ended
months ended
March 31,
December 31,
2024
2023
2023
Net income (loss) available to Genworth
Financial, Inc.'s common stockholders
$
139
$
122
$
(212
)
Add: net income attributable to
noncontrolling interests
30
32
29
Net income (loss)
169
154
(183
)
Less: loss from discontinued operations,
net of taxes
(1
)
—
(2
)
Income (loss) from continuing
operations
170
154
(181
)
Less: net income from continuing
operations attributable to noncontrolling interests
30
32
29
Income (loss) from continuing operations
available to Genworth Financial, Inc.'s common stockholders
140
122
(210
)
Adjustments to income (loss) from
continuing operations available to Genworth
Financial, Inc.'s common stockholders:
Net investment (gains) losses, net13
(50
)
11
(38
)
Changes in fair value of market risk
benefits attributable to interest rates, equity markets and
associated hedges14
(26
)
14
13
(Gains) losses on early extinguishment of
debt
(1
)
(1
)
(1
)
Expenses related to restructuring
7
3
—
Taxes on adjustments
15
(5
)
6
Adjusted operating income (loss)
$
85
$
144
$
(230
)
Adjusted operating income (loss):
Enact segment
$
135
$
143
$
129
Long-Term Care Insurance segment
3
23
(151
)
Life and Annuities segment:
Life Insurance
(33
)
(27
)
(206
)
Fixed Annuities
11
14
9
Variable Annuities
7
9
14
Total Life and Annuities segment
(15
)
(4
)
(183
)
Corporate and Other
(38
)
(18
)
(25
)
Adjusted operating income (loss)
$
85
$
144
$
(230
)
Net income (loss) available to Genworth
Financial, Inc.'s common stockholders per share:
Basic
$
0.31
$
0.25
$
(0.47
)
Diluted
$
0.31
$
0.24
$
(0.47
)
Adjusted operating income (loss) per
share:
Basic
$
0.19
$
0.29
$
(0.51
)
Diluted
$
0.19
$
0.29
$
(0.51
)
Weighted-average common shares
outstanding:
Basic
443.0
492.3
449.4
Diluted6
450.3
500.1
449.4
Footnote Definitions
________________________
1 Long-term care insurance.
2 All references reflect amounts available
to Genworth’s common stockholders.
3 This is a financial measure that is not
calculated based on U.S. Generally Accepted Accounting Principles
(GAAP). See the Use of Non-GAAP Measures section of this press
release for additional information.
4 Risk-based capital ratio based on
company action level for GLIC consolidated.
5 Company estimate for the first quarter
of 2024 due to timing of the preparation of the filing(s).
6 Under applicable accounting guidance,
companies in a loss position are required to use basic
weighted-average common shares outstanding in the calculation of
diluted loss per share. Therefore, as a result of the company’s
loss from continuing operations available to Genworth Financial,
Inc.’s common stockholders for the three months ended December 31,
2023, the company was required to use basic weighted-average common
shares outstanding in the calculation of diluted loss per share as
the inclusion of shares for performance stock units, restricted
stock units and other equity-based awards of 6.3 million would have
been antidilutive to the calculation. If the company had not
incurred a loss from continuing operations available to Genworth
Financial, Inc.’s common stockholders for the three months ended
December 31, 2023, dilutive potential weighted-average common
shares outstanding would have been 455.7 million.
7 Reflects Genworth’s ownership of equity
including accumulated other comprehensive income and excluding
noncontrolling interests of $873 million, $855 million and $793
million in the first quarter of 2024 and the fourth and first
quarters of 2023, respectively.
8 The Private Mortgage Insurer Eligibility
Requirements (PMIERs) sufficiency ratio is calculated as available
assets divided by required assets as defined within PMIERs.
9 Genworth’s principal U.S. life insurance
companies: GLIC, GLAIC and GLICNY.
10 Net gain from operations before
dividends to policyholders, refunds to members and federal income
taxes for Genworth Life Insurance Company (GLIC), Genworth Life and
Annuity Insurance Company (GLAIC) and Genworth Life Insurance
Company of New York (GLICNY), and before realized capital gains or
(losses).
11 Holding company cash and liquid assets
comprises assets held in Genworth Holdings, Inc. (the issuer of
outstanding public debt) which is a wholly-owned subsidiary of
Genworth Financial, Inc.
12 Genworth Holdings, Inc. held no
short-term investments or U.S. government securities as of March
31, 2024, December 31, 2023 and March 31, 2023.
13 Net investment (gains) losses were
adjusted for the portion attributable to noncontrolling interests
of $1 million for the three months ended March 31, 2024.
14 Changes in fair value of market risk
benefits and associated hedges were adjusted to exclude changes in
reserves, attributed fees and benefit payments of $(3) million for
both the three months ended March 31, 2024 and 2023 and $(1)
million for the three months ended December 31, 2023.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240501164213/en/
Investors: Sarah E. Crews InvestorInfo@genworth.com
Media: Amy Rein Amy.Rein@genworth.com
Genworth Financial (NYSE:GNW)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Genworth Financial (NYSE:GNW)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025